These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 17410817)

  • 21. Partnering for malpractice reform.
    Belfiglio G
    Healthplan; 2003; 44(2):12-6. PubMed ID: 12675003
    [No Abstract]   [Full Text] [Related]  

  • 22. The state of medical liability reform.
    Pollack J; Selzer D; Meara JG
    Bull Am Coll Surg; 2011 Jul; 96(7):22-5. PubMed ID: 22315898
    [No Abstract]   [Full Text] [Related]  

  • 23. PLI crisis states: doing battle with tort reform.
    Tenn Med; 2003 Apr; 96(4):170-1. PubMed ID: 12705001
    [No Abstract]   [Full Text] [Related]  

  • 24. Tort reform in medical malpractice.
    Regan J; Hamer G; Wright A; White C
    Tenn Med; 2004 Jul; 97(7):322-3. PubMed ID: 15359522
    [No Abstract]   [Full Text] [Related]  

  • 25. Tort reform in Oklahoma.
    Vanhooser JR
    J Okla State Med Assoc; 2009 Jan; 102(1):36. PubMed ID: 19271642
    [No Abstract]   [Full Text] [Related]  

  • 26. Too late, again?
    Jones NL
    Can Respir J; 2001; 8(3):127-8. PubMed ID: 11420587
    [No Abstract]   [Full Text] [Related]  

  • 27. Immunity for immunizations: tort liability, biodefense, and Bioshield II.
    Mayer L
    Stanford Law Rev; 2007 Apr; 59(6):1753-90. PubMed ID: 17593591
    [No Abstract]   [Full Text] [Related]  

  • 28. National tort reform: fixing what's broken.
    Williams B
    Tenn Med; 2003 Apr; 96(4):168-9. PubMed ID: 12705000
    [No Abstract]   [Full Text] [Related]  

  • 29. An empirical and critical look at the current medical liability crisis.
    Kinney ED
    Front Health Serv Manage; 2003; 20(1):31-7; discussion 39-42. PubMed ID: 14510316
    [No Abstract]   [Full Text] [Related]  

  • 30. Starting over. Docs vow to keep working for malpractice reform.
    Fong T
    Mod Healthc; 2003 Jul; 33(28):10-1. PubMed ID: 12884705
    [No Abstract]   [Full Text] [Related]  

  • 31. Loser pays laws are necessary to deter frivolous lawsuits.
    Gale AH
    Mo Med; 2006; 103(2):98-100. PubMed ID: 16703703
    [No Abstract]   [Full Text] [Related]  

  • 32. Companies to pay $39.5m in OxyContin and Risperdal cases.
    McCarthy M
    BMJ; 2015 Dec; 351():h7018. PubMed ID: 26721284
    [No Abstract]   [Full Text] [Related]  

  • 33. States weigh in. Legislatures helped stop push for national cap.
    Romano M
    Mod Healthc; 2003 Aug; 33(32):10-1. PubMed ID: 12931529
    [No Abstract]   [Full Text] [Related]  

  • 34. Other contingencies: reconsidering "loser pays".
    Gryphon M
    Mo Med; 2010; 107(1):10-5. PubMed ID: 20222287
    [No Abstract]   [Full Text] [Related]  

  • 35. US provides immunity from legal claims related to three Ebola vaccines.
    McCarthy M
    BMJ; 2014 Dec; 349():g7608. PubMed ID: 25499701
    [No Abstract]   [Full Text] [Related]  

  • 36. Malpractice reform is dead; long live malpractice reform.
    Scott JS
    Healthc Financ Manage; 2003 Sep; 57(9):32-4. PubMed ID: 14503140
    [No Abstract]   [Full Text] [Related]  

  • 37. ['No cure, no pay' in Dutch health care: fear of a culture of unwarranted claims].
    Legemaate J
    Ned Tijdschr Geneeskd; 2003 Apr; 147(16):740-2. PubMed ID: 12731462
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Significant increase in cost makes many processes unprofitable].
    Klin Monbl Augenheilkd; 2014 Apr; 231(4):297-8. PubMed ID: 24892169
    [No Abstract]   [Full Text] [Related]  

  • 39. Into the breach: a look at medical malpractice liability reform.
    Johnson P
    J Am Med Womens Assoc (1972); 2004; 59(2):80-1. PubMed ID: 15134420
    [No Abstract]   [Full Text] [Related]  

  • 40. Do these doctors give medicine a black eye?
    Rice B
    Med Econ; 2003 Dec; 80(24):58-62, 65, 69. PubMed ID: 14733056
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.